Taiyen Biotech Co (TPE:1737) EV-to-FCF: 37.29 (As of Jul. 10, 2026) — 74% Above Median


TPE:1737 Taiyen Biotech Co Ltd TPE:1737
83 GF Score
Price NT$31.90
GF Value NT$32.09
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Taiyen Biotech Co EV-to-FCF?

Taiyen Biotech Co TPE:1737 83 EV-to-FCF is 37.29 as of Jul. 10, 2026, which is 74% above its 10-year median of 21.43. GuruFocus rates TPE:1737 with a GF Score™ of 83/100 and a GF Value™ of NT$32.09 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,187 Consumer Packaged Goods companies, Taiyen Biotech Co ranks worse than 78.18% on this metric.

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Taiyen Biotech Co's Enterprise Value is NT$4,857 Mil. Taiyen Biotech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$130 Mil. Therefore, Taiyen Biotech Co's EV-to-FCF for today is 37.29.

The historical rank and industry rank for Taiyen Biotech Co's EV-to-FCF or its related term are showing as below:

TPE:1737' s EV-to-FCF Range Over the Past 10 Years
Min: -100119.37   Med: 21.43   Max: 362.56
Current: 37.52

During the past 13 years, the highest EV-to-FCF of Taiyen Biotech Co was 362.56. The lowest was -100119.37. And the median was 21.43.

TPE:1737's EV-to-FCF is ranked worse than
78.18% of 1187 companies
in the Consumer Packaged Goods industry
Industry Median: 15.85 vs TPE:1737: 37.52

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-10), Taiyen Biotech Co's stock price is NT$31.90. Taiyen Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1.990. Therefore, Taiyen Biotech Co's PE Ratio (TTM) for today is 16.03.


Taiyen Biotech Co  (TPE:1737) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Taiyen Biotech Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=31.90/1.990
=16.03

Taiyen Biotech Co's share price for today is NT$31.90.
Taiyen Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.990.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Taiyen Biotech Co EV-to-FCF Related Terms


Taiyen Biotech Co EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Taiyen Biotech Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiyen Biotech Co EV-to-FCF Chart

Taiyen Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.92 15.00 49.13 13.81 36.99

Taiyen Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.81 19.54 12.70 17.91 36.99

TPE:1737 vs PG, CL, KVUE: EV-to-FCF Comparison

For the Household & Personal Products subindustry, Taiyen Biotech Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiyen Biotech Co EV-to-FCF vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Taiyen Biotech Co's EV-to-FCF falls into.


TPE:1737
83GF Score
Taiyen Biotech Co Ltd TPE:1737
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Taiyen Biotech Co EV-to-FCF Calculation

Taiyen Biotech Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4857.431/130.253
=37.29

Taiyen Biotech Co's current Enterprise Value is NT$4,857 Mil.
Taiyen Biotech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$130 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-FCF →
What does a EV-to-FCF of 37.29 mean?
Taiyen Biotech Co (TPE:1737) has a EV-to-FCF of 37.29 as of Jul. 10, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Taiyen Biotech Co and its competitors. This is 74% above median its historical median of 21.43. According to the industry distribution chart, Taiyen Biotech Co ranks #928 out of 1187 companies in the Consumer Packaged Goods industry, placing it in the top 78.2%.
Is Taiyen Biotech Co's EV-to-FCF too high?
Taiyen Biotech Co's current EV-to-FCF of 37.29 is 74% above median its 10-year median of 21.43. The Consumer Packaged Goods industry median EV-to-FCF is 15.85. Taiyen Biotech Co's value of 37.29 is 135.3% above this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #928 out of 1187 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Taiyen Biotech Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's EV-to-FCF compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #928 out of 1187 companies for EV-to-FCF. This places Taiyen Biotech Co in the lower half of its industry. The industry median EV-to-FCF is 15.85. Taiyen Biotech Co's value of 37.29 is 135.3% above this benchmark. While the company's 10-year median is 21.43 vs. the industry median of 15.85, Taiyen Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.85, based on 1,187 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current EV-to-FCF of 37.29 is 135.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current EV-to-FCF is 37.29, which is 74% above median its own 10-year median of 21.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.09, compared to a current price of NT$31.90 — trading 0.6% below its estimated fair value. The current EV-to-FCF is 37.29, which is 74% above median its 10-year median of 21.43 and 135.3% above the Consumer Packaged Goods industry median of 15.85. Taiyen Biotech Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current EV-to-FCF is 37.29 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?

Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued. The current stock price of NT$31.90 is trading 0.6% below its estimated GF Value™ of NT$32.09. GuruFocus considers Taiyen Biotech Co to be Fairly Valued.

Key valuation signals for TPE:1737:

  • EV-to-FCF: 37.29 (74% above median its 10-year median of 21.43)
  • GF Value™: NT$32.09 vs. price of NT$31.90 (0.6% below fair value)
  • GF Score™: 83/100 with 1 warning sign
  • Industry Position: 135.3% above the Consumer Packaged Goods median (#928 of 1187)

No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Taiyen Biotech Co Business Description

Address No. 297, Section 1, Chien-Kang Road, South District, Tainan, TWN
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
83GF Score

Get the complete analysis for TPE:1737

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.90
Price
NT$32.09
GF Value